429 related articles for article (PubMed ID: 29204681)
1. [S1 guidelines Diagnostics and treatment of ANCA-associated vasculitis].
Schirmer JH; Aries PM; de Groot K; Hellmich B; Holle JU; Kneitz C; Kötter I; Lamprecht P; Müller-Ladner U; Reinhold-Keller E; Specker C; Zänker M; Moosig F
Z Rheumatol; 2017 Nov; 76(Suppl 3):77-104. PubMed ID: 29204681
[No Abstract] [Full Text] [Related]
2. [S1 guidelines on diagnostics and treatment of ANCA-associated vasculitis].
Schirmer JH; Moosig F
Z Rheumatol; 2017 Nov; 76(Suppl 3):75-76. PubMed ID: 29071483
[No Abstract] [Full Text] [Related]
3. [Laboratory diagnostics of ANCA-vasculitis].
Salamunić I; Kaliterna DM
Reumatizam; 2013; 60(2):39-42. PubMed ID: 24979995
[TBL] [Abstract][Full Text] [Related]
4. [New European guidelines for the management of ANCA-associated vasculitis].
Terrier B
Rev Med Interne; 2023 Jun; 44(6):271-273. PubMed ID: 37150639
[No Abstract] [Full Text] [Related]
5. Testing and reporting antineutrophil cytoplasmic antibodies (ANCA) in treated vasculitis and non-vasculitic disease.
Savige J; Trevisin M; Pollock W
J Immunol Methods; 2018 Jul; 458():1-7. PubMed ID: 29486145
[TBL] [Abstract][Full Text] [Related]
6. The future of ANCA-associated vasculitis.
Holle JU; Wieczorek S; Gross WL
Rheum Dis Clin North Am; 2010 Aug; 36(3):609-21. PubMed ID: 20688253
[TBL] [Abstract][Full Text] [Related]
7. ANCA-associated renal vasculitis.
Ríhová Z
Acta Univ Carol Med Monogr; 2009; 157():5-46. PubMed ID: 20608331
[No Abstract] [Full Text] [Related]
8. ANCA associated vasculitis.
Hunter RW; Welsh N; Farrah TE; Gallacher PJ; Dhaun N
BMJ; 2020 Apr; 369():m1070. PubMed ID: 32291255
[No Abstract] [Full Text] [Related]
9. Clinical significance of positive anti-neutrophil cytoplasmic antibodies without evidence of anti-neutrophil cytoplasmic antibodies-associated vasculitis.
Bornstein G; Ben-Zvi I; Furie N; Grossman C
Int J Rheum Dis; 2019 May; 22(5):940-945. PubMed ID: 30729688
[TBL] [Abstract][Full Text] [Related]
10. Diagnostic outcome and indications for testing in patients with positive ANCA at a Canadian tertiary care centre.
Chehroudi C; Booth RA; Milman N
Rheumatol Int; 2018 Apr; 38(4):641-647. PubMed ID: 29243051
[TBL] [Abstract][Full Text] [Related]
11. L1. Pathogenesis of ANCA-associated vasculitis: observations, theories and speculations.
Charles Jennette J; Falk RJ
Presse Med; 2013 Apr; 42(4 Pt 2):493-8. PubMed ID: 23465301
[No Abstract] [Full Text] [Related]
12. A dual-fixed neutrophil substrate improves interpretation of antineutrophil cytoplasmic antibodies by indirect immunofluorescence.
Lin MW; Silvestrini RA; Culican S; Campbell D; Fulcher DA
Am J Clin Pathol; 2014 Sep; 142(3):325-30. PubMed ID: 25125622
[TBL] [Abstract][Full Text] [Related]
13. Antineutrophil cytoplasmic antibody (ANCA) testing: Audit from a clinical immunology laboratory.
Phatak S; Aggarwal A; Agarwal V; Lawrence A; Misra R
Int J Rheum Dis; 2017 Jun; 20(6):774-778. PubMed ID: 27457216
[TBL] [Abstract][Full Text] [Related]
14. Diagnostic value of distinguishing and reporting different perinuclear ANCA (P-ANCA) immunofluorescence patterns: a prospective study.
Perel SB; Prain KM; Wilson RJ; Hogan PG; Gillis D; Wong RC
Am J Clin Pathol; 2013 Aug; 140(2):184-92. PubMed ID: 23897253
[TBL] [Abstract][Full Text] [Related]
15. [ANCA-associated vasculitis: recent methodological advances for ANCA detection].
Csernok E
Dtsch Med Wochenschr; 2018 Apr; 143(7):499-502. PubMed ID: 29614541
[TBL] [Abstract][Full Text] [Related]
16. [Primary systemic ANCA-associated vasculitis--recommendations concerning diagnosis and treatment].
Wiatr E; Gawryluk D
Pneumonol Alergol Pol; 2013; 81(5):479-91. PubMed ID: 23996888
[No Abstract] [Full Text] [Related]
17. Increase of Antimyeloperoxidase Antineutrophil Cytoplasmic Antibody (ANCA) in Patients with Renal ANCA-associated Vasculitis: Association with Risk to Relapse.
Yamaguchi M; Ando M; Kato S; Katsuno T; Kato N; Kosugi T; Sato W; Tsuboi N; Yasuda Y; Mizuno M; Ito Y; Matsuo S; Maruyama S
J Rheumatol; 2015 Oct; 42(10):1853-60. PubMed ID: 26373560
[TBL] [Abstract][Full Text] [Related]
18. Anti-neutrophil extracellular trap antibody in a patient with relapse of anti-neutrophil cytoplasmic antibody-associated vasculitis: a case report.
Shida H; Hashimoto N; Kusunoki Y; Hattanda F; Ogawa Y; Hayashi T; Nakazawa D; Masuda S; Tomaru U; Ishizu A
BMC Nephrol; 2018 Jun; 19(1):145. PubMed ID: 29929470
[TBL] [Abstract][Full Text] [Related]
19. Antineutrophilic cytoplasmic antibody-associated vasculitis and malignant hemopathies, a retrospective study of 16 cases.
Philipponnet C; Garrouste C; Le Guenno G; Cartery C; Guillevin L; Boffa JJ; Heng AE
Joint Bone Spine; 2017 Jan; 84(1):51-57. PubMed ID: 27118022
[TBL] [Abstract][Full Text] [Related]
20. An unusual presentation of C-ANCA vasculitis.
Gavrilovski M; Kakar P; Rendle J; Lawrence E; Kee K; Sathanathan R
QJM; 2012 Nov; 105(11):1105-7. PubMed ID: 21920993
[No Abstract] [Full Text] [Related]
[Next] [New Search]
